Neutralizing ZIKV Antibody Assay
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : National Taiwan University
Variable analysis
- Antibody concentration (two-fold serial dilutions starting from 100 μg/mL or 10 μg/mL)
- Neutralizing activity of the antibodies against ZIKV
- Virus titer (100 PFU of ZIKV)
- Cell line (Vero cell monolayers)
- Incubation time (1 h at 37°C for antibody-virus complexes, 2 h for antibody-virus complexes added to Vero cells)
- Cell culture conditions (DMEM supplemented with 2% FBS and 1% non-essential amino acid, 1.8% (w/v) methylcellulose overlay)
- Mouse anti-ZIKV E protein mAb, clone ZV-54 (MABF2046, Merck Ltd.), with known neutralizing activity
- PBS control
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!